A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies

Clinical trial NCT06974734 · TERMINATED

Trial details

NCT number: NCT06974734
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non Small Cell Lung Carcinoma, Pancreatic Ductal Malignant Melanoma Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Start date: 2025-05-06
Primary completion: 2026-03-20
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.